世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界および日本の抗コリン性旅行酔い止め薬市場の洞察、2027年までの予測


Global and Japan Anticholinergic Travel Sickness Drugs Market Insights, Forecast to 2027

乗り物酔いは、自動車、列車、飛行機、そして特に船で旅行する人によく見られる問題です。乗り物酔いは、視覚的に認識された動きと前庭系の動きの感覚の違いによって患者が経験する症状です。乗り物酔いは、吐き... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2021年10月14日 US$3,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

乗り物酔いは、自動車、列車、飛行機、そして特に船で旅行する人によく見られる問題です。乗り物酔いは、視覚的に認識された動きと前庭系の動きの感覚の違いによって患者が経験する症状です。乗り物酔いは、吐き気、疲労感、めまいなどの一連の症状で特徴づけられます。

市場分析と洞察。世界と日本の抗コリン性旅行酔い治療薬市場
本レポートでは、世界と日本の抗コリン性旅行酔い止め薬市場に焦点を当てています。
2020年の抗コリン性旅行酔い薬の世界市場規模はXX百万米ドルで、2021-2027年の間にXX%のCAGRで、2027年末にはXX百万米ドルに達すると予想されています。日本では、抗コリン性旅行酔い薬の市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX%のCAGRで成長すると予測されています。

抗コリン性旅行酔い薬の世界的な規模と市場規模
抗コリン性旅行酔い薬の市場は、地域(国)別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のAnticholinergic Travel Sickness Drugs市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、地域(国)別、タイプ別、アプリケーション別に、2016年から2027年までの収益と予測に焦点を当てています。
日本市場では、2016-2027年の期間で、プレイヤー別、タイプ別、アプリケーション別の抗コリン性旅行酔い止め薬の市場規模に焦点を当てています。主要プレイヤーには、日本で重要な役割を果たしているグローバルプレイヤーとローカルプレイヤーが含まれています。

タイプ別セグメント
大人用
小児

用途別セグメント
病院
ドラッグストア
その他

地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
U.A.E.

会社別
GlaxoSmithKline(グラクソ・スミスクライン
バクスター・インターナショナル


ページTOPに戻る


目次

1 Study Coverage
1.1 Anticholinergic Travel Sickness Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Anticholinergic Travel Sickness Drugs Market Size Growth Rate by Type
1.2.2 Adults
1.2.3 Children
1.3 Market by Application
1.3.1 Global Anticholinergic Travel Sickness Drugs Market Size Growth Rate by Application
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Anticholinergic Travel Sickness Drugs Market Size, Estimates and Forecasts
2.1.1 Global Anticholinergic Travel Sickness Drugs Revenue 2016-2027
2.1.2 Global Anticholinergic Travel Sickness Drugs Sales 2016-2027
2.2 Global Anticholinergic Travel Sickness Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Anticholinergic Travel Sickness Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Anticholinergic Travel Sickness Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Anticholinergic Travel Sickness Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Anticholinergic Travel Sickness Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Anticholinergic Travel Sickness Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Anticholinergic Travel Sickness Drugs Revenue Forecast by Region (2022-2027)

3 Global Anticholinergic Travel Sickness Drugs Competitor Landscape by Players
3.1 Global Top Anticholinergic Travel Sickness Drugs Manufacturers by Sales
3.1.1 Global Anticholinergic Travel Sickness Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Anticholinergic Travel Sickness Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Anticholinergic Travel Sickness Drugs Manufacturers by Revenue
3.2.1 Key Anticholinergic Travel Sickness Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Anticholinergic Travel Sickness Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Anticholinergic Travel Sickness Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Anticholinergic Travel Sickness Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Anticholinergic Travel Sickness Drugs Revenue in 2020
3.2.6 Global Anticholinergic Travel Sickness Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Anticholinergic Travel Sickness Drugs Price by Manufacturers
3.4 Global Anticholinergic Travel Sickness Drugs Manufacturing Base Distribution, Product Types
3.4.1 Anticholinergic Travel Sickness Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anticholinergic Travel Sickness Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Anticholinergic Travel Sickness Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Anticholinergic Travel Sickness Drugs Market Size by Type (2016-2021)
4.1.1 Global Anticholinergic Travel Sickness Drugs Sales by Type (2016-2021)
4.1.2 Global Anticholinergic Travel Sickness Drugs Revenue by Type (2016-2021)
4.1.3 Anticholinergic Travel Sickness Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Anticholinergic Travel Sickness Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Anticholinergic Travel Sickness Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Anticholinergic Travel Sickness Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Anticholinergic Travel Sickness Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Anticholinergic Travel Sickness Drugs Market Size by Application (2016-2021)
5.1.1 Global Anticholinergic Travel Sickness Drugs Sales by Application (2016-2021)
5.1.2 Global Anticholinergic Travel Sickness Drugs Revenue by Application (2016-2021)
5.1.3 Anticholinergic Travel Sickness Drugs Price by Application (2016-2021)
5.2 Anticholinergic Travel Sickness Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Anticholinergic Travel Sickness Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Anticholinergic Travel Sickness Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Anticholinergic Travel Sickness Drugs Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
6.1 Japan Anticholinergic Travel Sickness Drugs Market Size YoY Growth 2016-2027
6.1.1 Japan Anticholinergic Travel Sickness Drugs Sales YoY Growth 2016-2027
6.1.2 Japan Anticholinergic Travel Sickness Drugs Revenue YoY Growth 2016-2027
6.1.3 Japan Anticholinergic Travel Sickness Drugs Market Share in Global Market 2016-2027
6.2 Japan Anticholinergic Travel Sickness Drugs Market Size by Players (International and Local Players)
6.2.1 Japan Top Anticholinergic Travel Sickness Drugs Players by Sales (2016-2021)
6.2.2 Japan Top Anticholinergic Travel Sickness Drugs Players by Revenue (2016-2021)
6.3 Japan Anticholinergic Travel Sickness Drugs Historic Market Review by Type (2016-2021)
6.3.1 Japan Anticholinergic Travel Sickness Drugs Sales Market Share by Type (2016-2021)
6.3.2 Japan Anticholinergic Travel Sickness Drugs Revenue Market Share by Type (2016-2021)
6.3.3 Japan Anticholinergic Travel Sickness Drugs Price by Type (2016-2021)
6.4 Japan Anticholinergic Travel Sickness Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Anticholinergic Travel Sickness Drugs Sales Forecast by Type (2022-2027)
6.4.2 Japan Anticholinergic Travel Sickness Drugs Revenue Forecast by Type (2022-2027)
6.4.3 Japan Anticholinergic Travel Sickness Drugs Price Forecast by Type (2022-2027)
6.5 Japan Anticholinergic Travel Sickness Drugs Historic Market Review by Application (2016-2021)
6.5.1 Japan Anticholinergic Travel Sickness Drugs Sales Market Share by Application (2016-2021)
6.5.2 Japan Anticholinergic Travel Sickness Drugs Revenue Market Share by Application (2016-2021)
6.5.3 Japan Anticholinergic Travel Sickness Drugs Price by Application (2016-2021)
6.6 Japan Anticholinergic Travel Sickness Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Anticholinergic Travel Sickness Drugs Sales Forecast by Application (2022-2027)
6.6.2 Japan Anticholinergic Travel Sickness Drugs Revenue Forecast by Application (2022-2027)
6.6.3 Japan Anticholinergic Travel Sickness Drugs Price Forecast by Application (2022-2027)

7 North America
7.1 North America Anticholinergic Travel Sickness Drugs Market Size YoY Growth 2016-2027
7.2 North America Anticholinergic Travel Sickness Drugs Market Facts & Figures by Country
7.2.1 North America Anticholinergic Travel Sickness Drugs Sales by Country (2016-2021)
7.2.2 North America Anticholinergic Travel Sickness Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Anticholinergic Travel Sickness Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Anticholinergic Travel Sickness Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Anticholinergic Travel Sickness Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Anticholinergic Travel Sickness Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Anticholinergic Travel Sickness Drugs Market Size YoY Growth 2016-2027
9.2 Europe Anticholinergic Travel Sickness Drugs Market Facts & Figures by Country
9.2.1 Europe Anticholinergic Travel Sickness Drugs Sales by Country (2016-2021)
9.2.2 Europe Anticholinergic Travel Sickness Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Anticholinergic Travel Sickness Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Anticholinergic Travel Sickness Drugs Market Facts & Figures by Country
10.2.1 Latin America Anticholinergic Travel Sickness Drugs Sales by Country (2016-2021)
10.2.2 Latin America Anticholinergic Travel Sickness Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Anticholinergic Travel Sickness Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Anticholinergic Travel Sickness Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Anticholinergic Travel Sickness Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Anticholinergic Travel Sickness Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Corporation Information
12.1.2 GlaxoSmithKline Description and Business Overview
12.1.3 GlaxoSmithKline Anticholinergic Travel Sickness Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GlaxoSmithKline Anticholinergic Travel Sickness Drugs Products Offered
12.1.5 GlaxoSmithKline Recent Development
12.2 Baxter International
12.2.1 Baxter International Corporation Information
12.2.2 Baxter International Description and Business Overview
12.2.3 Baxter International Anticholinergic Travel Sickness Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Baxter International Anticholinergic Travel Sickness Drugs Products Offered
12.2.5 Baxter International Recent Development
12.11 GlaxoSmithKline
12.11.1 GlaxoSmithKline Corporation Information
12.11.2 GlaxoSmithKline Description and Business Overview
12.11.3 GlaxoSmithKline Anticholinergic Travel Sickness Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GlaxoSmithKline Anticholinergic Travel Sickness Drugs Products Offered
12.11.5 GlaxoSmithKline Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Anticholinergic Travel Sickness Drugs Industry Trends
13.2 Anticholinergic Travel Sickness Drugs Market Drivers
13.3 Anticholinergic Travel Sickness Drugs Market Challenges
13.4 Anticholinergic Travel Sickness Drugs Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anticholinergic Travel Sickness Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

 

ページTOPに戻る


 

Summary

Travel Sickness is a common problem in people traveling by car, train, airplanes, and especially boats. Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.

Market Analysis and Insights: Global and Japan Anticholinergic Travel Sickness Drugs Market
This report focuses on global and Japan Anticholinergic Travel Sickness Drugs market.
In 2020, the global Anticholinergic Travel Sickness Drugs market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In Japan the Anticholinergic Travel Sickness Drugs market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Anticholinergic Travel Sickness Drugs Scope and Market Size
Anticholinergic Travel Sickness Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Anticholinergic Travel Sickness Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Anticholinergic Travel Sickness Drugs market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type
Adults
Children

Segment by Application
Hospitals
Drugstores
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
GlaxoSmithKline
Baxter International



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Anticholinergic Travel Sickness Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Anticholinergic Travel Sickness Drugs Market Size Growth Rate by Type
1.2.2 Adults
1.2.3 Children
1.3 Market by Application
1.3.1 Global Anticholinergic Travel Sickness Drugs Market Size Growth Rate by Application
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Anticholinergic Travel Sickness Drugs Market Size, Estimates and Forecasts
2.1.1 Global Anticholinergic Travel Sickness Drugs Revenue 2016-2027
2.1.2 Global Anticholinergic Travel Sickness Drugs Sales 2016-2027
2.2 Global Anticholinergic Travel Sickness Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Anticholinergic Travel Sickness Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Anticholinergic Travel Sickness Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Anticholinergic Travel Sickness Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Anticholinergic Travel Sickness Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Anticholinergic Travel Sickness Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Anticholinergic Travel Sickness Drugs Revenue Forecast by Region (2022-2027)

3 Global Anticholinergic Travel Sickness Drugs Competitor Landscape by Players
3.1 Global Top Anticholinergic Travel Sickness Drugs Manufacturers by Sales
3.1.1 Global Anticholinergic Travel Sickness Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Anticholinergic Travel Sickness Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Anticholinergic Travel Sickness Drugs Manufacturers by Revenue
3.2.1 Key Anticholinergic Travel Sickness Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Anticholinergic Travel Sickness Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Anticholinergic Travel Sickness Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Anticholinergic Travel Sickness Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Anticholinergic Travel Sickness Drugs Revenue in 2020
3.2.6 Global Anticholinergic Travel Sickness Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Anticholinergic Travel Sickness Drugs Price by Manufacturers
3.4 Global Anticholinergic Travel Sickness Drugs Manufacturing Base Distribution, Product Types
3.4.1 Anticholinergic Travel Sickness Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anticholinergic Travel Sickness Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Anticholinergic Travel Sickness Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Anticholinergic Travel Sickness Drugs Market Size by Type (2016-2021)
4.1.1 Global Anticholinergic Travel Sickness Drugs Sales by Type (2016-2021)
4.1.2 Global Anticholinergic Travel Sickness Drugs Revenue by Type (2016-2021)
4.1.3 Anticholinergic Travel Sickness Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Anticholinergic Travel Sickness Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Anticholinergic Travel Sickness Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Anticholinergic Travel Sickness Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Anticholinergic Travel Sickness Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Anticholinergic Travel Sickness Drugs Market Size by Application (2016-2021)
5.1.1 Global Anticholinergic Travel Sickness Drugs Sales by Application (2016-2021)
5.1.2 Global Anticholinergic Travel Sickness Drugs Revenue by Application (2016-2021)
5.1.3 Anticholinergic Travel Sickness Drugs Price by Application (2016-2021)
5.2 Anticholinergic Travel Sickness Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Anticholinergic Travel Sickness Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Anticholinergic Travel Sickness Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Anticholinergic Travel Sickness Drugs Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
6.1 Japan Anticholinergic Travel Sickness Drugs Market Size YoY Growth 2016-2027
6.1.1 Japan Anticholinergic Travel Sickness Drugs Sales YoY Growth 2016-2027
6.1.2 Japan Anticholinergic Travel Sickness Drugs Revenue YoY Growth 2016-2027
6.1.3 Japan Anticholinergic Travel Sickness Drugs Market Share in Global Market 2016-2027
6.2 Japan Anticholinergic Travel Sickness Drugs Market Size by Players (International and Local Players)
6.2.1 Japan Top Anticholinergic Travel Sickness Drugs Players by Sales (2016-2021)
6.2.2 Japan Top Anticholinergic Travel Sickness Drugs Players by Revenue (2016-2021)
6.3 Japan Anticholinergic Travel Sickness Drugs Historic Market Review by Type (2016-2021)
6.3.1 Japan Anticholinergic Travel Sickness Drugs Sales Market Share by Type (2016-2021)
6.3.2 Japan Anticholinergic Travel Sickness Drugs Revenue Market Share by Type (2016-2021)
6.3.3 Japan Anticholinergic Travel Sickness Drugs Price by Type (2016-2021)
6.4 Japan Anticholinergic Travel Sickness Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Anticholinergic Travel Sickness Drugs Sales Forecast by Type (2022-2027)
6.4.2 Japan Anticholinergic Travel Sickness Drugs Revenue Forecast by Type (2022-2027)
6.4.3 Japan Anticholinergic Travel Sickness Drugs Price Forecast by Type (2022-2027)
6.5 Japan Anticholinergic Travel Sickness Drugs Historic Market Review by Application (2016-2021)
6.5.1 Japan Anticholinergic Travel Sickness Drugs Sales Market Share by Application (2016-2021)
6.5.2 Japan Anticholinergic Travel Sickness Drugs Revenue Market Share by Application (2016-2021)
6.5.3 Japan Anticholinergic Travel Sickness Drugs Price by Application (2016-2021)
6.6 Japan Anticholinergic Travel Sickness Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Anticholinergic Travel Sickness Drugs Sales Forecast by Application (2022-2027)
6.6.2 Japan Anticholinergic Travel Sickness Drugs Revenue Forecast by Application (2022-2027)
6.6.3 Japan Anticholinergic Travel Sickness Drugs Price Forecast by Application (2022-2027)

7 North America
7.1 North America Anticholinergic Travel Sickness Drugs Market Size YoY Growth 2016-2027
7.2 North America Anticholinergic Travel Sickness Drugs Market Facts & Figures by Country
7.2.1 North America Anticholinergic Travel Sickness Drugs Sales by Country (2016-2021)
7.2.2 North America Anticholinergic Travel Sickness Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Anticholinergic Travel Sickness Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Anticholinergic Travel Sickness Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Anticholinergic Travel Sickness Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Anticholinergic Travel Sickness Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Anticholinergic Travel Sickness Drugs Market Size YoY Growth 2016-2027
9.2 Europe Anticholinergic Travel Sickness Drugs Market Facts & Figures by Country
9.2.1 Europe Anticholinergic Travel Sickness Drugs Sales by Country (2016-2021)
9.2.2 Europe Anticholinergic Travel Sickness Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Anticholinergic Travel Sickness Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Anticholinergic Travel Sickness Drugs Market Facts & Figures by Country
10.2.1 Latin America Anticholinergic Travel Sickness Drugs Sales by Country (2016-2021)
10.2.2 Latin America Anticholinergic Travel Sickness Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Anticholinergic Travel Sickness Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Anticholinergic Travel Sickness Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Anticholinergic Travel Sickness Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Anticholinergic Travel Sickness Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Corporation Information
12.1.2 GlaxoSmithKline Description and Business Overview
12.1.3 GlaxoSmithKline Anticholinergic Travel Sickness Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GlaxoSmithKline Anticholinergic Travel Sickness Drugs Products Offered
12.1.5 GlaxoSmithKline Recent Development
12.2 Baxter International
12.2.1 Baxter International Corporation Information
12.2.2 Baxter International Description and Business Overview
12.2.3 Baxter International Anticholinergic Travel Sickness Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Baxter International Anticholinergic Travel Sickness Drugs Products Offered
12.2.5 Baxter International Recent Development
12.11 GlaxoSmithKline
12.11.1 GlaxoSmithKline Corporation Information
12.11.2 GlaxoSmithKline Description and Business Overview
12.11.3 GlaxoSmithKline Anticholinergic Travel Sickness Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GlaxoSmithKline Anticholinergic Travel Sickness Drugs Products Offered
12.11.5 GlaxoSmithKline Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Anticholinergic Travel Sickness Drugs Industry Trends
13.2 Anticholinergic Travel Sickness Drugs Market Drivers
13.3 Anticholinergic Travel Sickness Drugs Market Challenges
13.4 Anticholinergic Travel Sickness Drugs Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anticholinergic Travel Sickness Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/25 10:25

158.38 円

165.32 円

201.48 円

ページTOPに戻る